Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $748000.0.

  • RxSight's Other Non-Current Assets rose 520.39% to $748000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $748000.0, marking a year-over-year increase of 520.39%. This contributed to the annual value of $750000.0 for FY2024, which is 548.52% up from last year.
  • Latest data reveals that RxSight reported Other Non-Current Assets of $748000.0 as of Q3 2025, which was up 520.39% from $750000.0 recorded in Q2 2025.
  • In the past 5 years, RxSight's Other Non-Current Assets ranged from a high of $1.3 million in Q2 2021 and a low of $561000.0 during Q3 2021
  • Moreover, its 5-year median value for Other Non-Current Assets was $750000.0 (2024), whereas its average is $777277.8.
  • In the last 5 years, RxSight's Other Non-Current Assets skyrocketed by 7592.19% in 2021 and then plummeted by 3965.77% in 2022.
  • Over the past 5 years, RxSight's Other Non-Current Assets (Quarter) stood at $811000.0 in 2021, then decreased by 5.43% to $767000.0 in 2022, then decreased by 7.3% to $711000.0 in 2023, then increased by 5.49% to $750000.0 in 2024, then dropped by 0.27% to $748000.0 in 2025.
  • Its Other Non-Current Assets was $748000.0 in Q3 2025, compared to $750000.0 in Q2 2025 and $750000.0 in Q1 2025.